Logo ActuIA ActuIA

AI news from France

Français Español Italiano Deutsch Nederlands Română Polski Português العربية Türkçe Українська 中文 日本語 한국어
Publish
Home
AI Watch

By category

Funding Mergers & acquisitions Model release Product launch Partnership Public program / call for projects Regulation & governance Litigation Research & science Deployment & adoption Infrastructure & compute Corporate & strategy Security & incident Report & study Event

By sector

Company Culture Defense Education Finance Fundamental Research Health - medicine Industry Insurance Justice Marketing Media Risk Prevention Social networks Telecommunications Transport

By category

Funding Mergers & acquisitions Model release Product launch Partnership Public program / call for projects Regulation & governance Litigation Research & science Deployment & adoption Infrastructure & compute Corporate & strategy Security & incident Report & study Event

By sector

Company Culture Defense Education Finance Fundamental Research Health - medicine Industry Insurance Justice Marketing Media Risk Prevention Social networks Telecommunications Transport
Latest news
Language

MAbSilico

MAbSilico est un éditeur de logiciels ayant la vision d'accélérer le développement d'anticorps thérapeutiques en utilisant des solutions pilotées par deeptech combinant l'intelligence artificielle et l'apprentissage automatique.

1 articles liés à cet acteur

Research project looks at AI for designing antibody fragments in female contraception

Research project looks at AI for designing antibody fragments in female contraception

INRAE is leading a consortium composed of IN-CELL-ART, MabSilico and the Italian university UNIMORE to develop biological products based on antibody f...

Mar 26, 2021 Read more →
Logo ActuIA Logo ActuIA

Your source of information on artificial intelligence and its advances.

Navigation

  • Legal notice
  • Contact

Follow us

© 2019-2026 Net Square Digital. All rights reserved.